Levonorgestrel-releasing intrauterine system (Mirena) for contraception

American Family Physician

Volumn 73, Issue 10, 2006, Pages 1799-1802

  McCarthy, Lisa ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

CONTRACEPTION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECTOPIC PREGNANCY; INCIDENCE; INTRAUTERINE CONTRACEPTIVE DEVICE; PELVIC INFLAMMATORY DISEASE; REVIEW;

EID: 33744500208     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Mirena (levonorgestrel-releasing intrauterine system). Product information. Montville, N.J.: Berlex, 2004. Accessed online February 28, 2006, at: http://www.berlex.com/html/products/pi/Mirena_PI.pdf.
2. Shulman LP, Nelson AL, Darney PD. Recent developments in hormone delivery systems. Am J Obset Gynecol 2004;190(4 suppl):S39-48.
3. Black A. Intrauterine devices. In: SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can 2004;26:219-96.
4. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72.
5. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 1992;46:575-84.
6. Grimes D, Schulz K, van Vliet H, Stanwood N. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 2001;(2):CD003036.
7. Ito S. Drug therapy for breast-feeding women [published correction appears in N Engl J Med 2000;343:1348]. N Engl J Med 2000;343:118-26.
8. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-21.
9. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa e Silva JC, Podgaec S, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993-8.
10. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-63.
11. Faundes A, Alvarez F, Brache V, Tejada AS. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation. Int J Gynaecol Obstet 1988;26:429-33.
12. Boon J, Scholten PC, Oldenhave A, Heintz AP. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. Maturitas 2003;46:69-77.
13. Dailard C. The cost of contraceptive insurance coverage. Guttmacher Report on Public Policy, March 2003. Accessed online February 28, 2006, at: http://www.guttmacher.org/pubs/ib_4-03.html.